Molecular imaging in gastroenterology

Molecular imaging is a novel field in gastroenterology that uses fluorescently labelled probes to specifically highlight neoplastic lesions on the basis of their molecular signature. The development of molecular imaging has been driven by the need to improve endoscopic diagnosis and by progress in targeted therapies in gastrointestinal oncology to provide individualized treatment, which coincides with progress in endoscopy techniques and further miniaturization of detection devices. Different exogenous molecular probes for imaging include labelled antibodies, oligopeptides, affibodies™ (Affibody AB, Bromma, Sweden), aptamers and activatable probes. Molecular imaging has been evaluated in two major indications: many trials have studied molecular imaging as a red flag technique to improve detection of lesions in wide-field imaging; on the other hand, microscopic analysis has been investigated for in vivo characterization of the molecular fingerprint of tumours with the ultimate goal of assessing the likelihood of response to targeted therapy. This Review focusses on the applications of molecular imaging that have immediate potential for translational science or imminent transition into clinical practice of gastrointestinal endoscopy.

[1]  Kenneth K Wang,et al.  Endoscopic tri-modal imaging for detection of early neoplasia in Barrett’s oesophagus: a multi-centre feasibility study using high-resolution endoscopy, autofluorescence imaging and narrow band imaging incorporated in one endoscopy system , 2007, Gut.

[2]  A. Lièvre,et al.  KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Thomas D. Wang.  Targeted imaging of neoplasia in the digestive tract. , 2008, Cancer Biomarkers.

[4]  Paul Collins,et al.  Colonoscopic withdrawal times and adenoma detection during screening colonoscopy , 2007 .

[5]  D. Cunningham,et al.  Integration of biologic agents with cytotoxic chemotherapy in metastatic colorectal cancer. , 2011, Clinical colorectal cancer.

[6]  Thomas D. Wang,et al.  Molecular imaging in gastrointestinal endoscopy. , 2010, Gastroenterology.

[7]  Thomas D. Wang,et al.  Near-infrared-labeled peptide multimer functions as phage mimic for high affinity, specific targeting of colonic adenomas in vivo (with videos). , 2012, Gastrointestinal endoscopy.

[8]  Thomas D. Wang,et al.  In vivo targeting of colonic dysplasia on fluorescence endoscopy with near-infrared octapeptide , 2012, Gut.

[9]  Ralph Weissleder,et al.  Detection of Invasive Colon Cancer Using a Novel, Targeted, Library-Derived Fluorescent Peptide , 2004, Cancer Research.

[10]  Hak Soo Choi,et al.  Nanoparticles for Biomedical Imaging: Fundamentals of Clinical Translation , 2010, Molecular imaging.

[11]  Michael Vieth,et al.  In vivo molecular imaging of colorectal cancer with confocal endomicroscopy by targeting epidermal growth factor receptor. , 2010, Gastroenterology.

[12]  N. Boku,et al.  Endoscopic evaluation of primary tumor response in patients with metastatic colorectal cancer treated by systemic chemotherapy , 2013, International Journal of Clinical Oncology.

[13]  Yoon-Koo Kang,et al.  Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial , 2010, The Lancet.

[14]  Thomas D. Wang,et al.  Affinity peptide for targeted detection of dysplasia in Barrett's esophagus. , 2010, Gastroenterology.

[15]  Umar Mahmood,et al.  Optical imaging of periostin enables early endoscopic detection and characterization of esophageal cancer in mice. , 2013, Gastroenterology.

[16]  L. Abrahmsén,et al.  Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy , 2007, Expert opinion on biological therapy.

[17]  R. Pirker,et al.  Monoclonal antibodies against EGFR in non-small cell lung cancer. , 2011, Critical reviews in oncology/hematology.

[18]  Martin Goetz,et al.  Microscopic imaging in endoscopy: endomicroscopy and endocytoscopy , 2014, Nature Reviews Gastroenterology &Hepatology.

[19]  Rebecca C Fitzgerald,et al.  Molecular imaging using fluorescent lectins permits rapid endoscopic identification of dysplasia in Barrett's esophagus , 2012, Nature Medicine.

[20]  C. Lightdale,et al.  The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract , 2010, Alimentary pharmacology & therapeutics.

[21]  Christopher H Contag,et al.  Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy. , 2008, Nature medicine.

[22]  J Mudter,et al.  High definition colonoscopy combined with i-Scan is superior in the detection of colorectal neoplasias compared with standard video colonoscopy: a prospective randomized controlled trial. , 2010, Endoscopy.

[23]  Ron C. Hardman.  A Toxicologic Review of Quantum Dots: Toxicity Depends on Physicochemical and Environmental Factors , 2005, Environmental health perspectives.

[24]  Manal M. Hassan,et al.  The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors: Well-Differentiated Neuroendocrine Tumors of the Jejunum, Ileum, Appendix, and Cecum , 2010, Pancreas.

[25]  Ralph Weissleder,et al.  Targeted imaging of human endothelial-specific marker in a model of adoptive cell transfer , 2006, Laboratory Investigation.

[26]  Roger Kurlan,et al.  Current Concepts , 2022 .

[27]  R Weissleder,et al.  Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model. , 2001, Radiology.

[28]  M. Christian,et al.  [New guidelines to evaluate the response to treatment in solid tumors]. , 2000, Bulletin du cancer.

[29]  Markus F Neurath,et al.  Molecular imaging of VEGF in gastrointestinal cancer in vivo using confocal laser endomicroscopy , 2010, Gut.

[30]  Weihong Tan,et al.  DNA Aptamers as Molecular Probes for Colorectal Cancer Study , 2010, PloS one.

[31]  R. Kiesslich,et al.  In vivo molecular imaging of epidermal growth factor receptor in patients with colorectal neoplasia using confocal laser endomicroscopy. , 2013, Cancer letters.

[32]  Michael Vieth,et al.  Near-infrared confocal imaging during mini-laparoscopy: a novel rigid endomicroscope with increased imaging plane depth. , 2010, Journal of hepatology.

[33]  D. Bates,et al.  Focused ultrasound treatment of abscesses induced by methicillin resistant Staphylococcus aureus: feasibility study in a mouse model. , 2014, Medical physics.

[34]  R. Kiesslich,et al.  In vivo molecular imaging of somatostatin receptors in pancreatic islet cells and neuroendocrine tumors by miniaturized confocal laser-scanning fluorescence microscopy. , 2010, Endocrinology.

[35]  V. Prasad,et al.  Molecular Imaging of HER2-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic 111In- or 68Ga-Labeled Affibody Molecules , 2010, Journal of Nuclear Medicine.

[36]  P. Low,et al.  Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results , 2011, Nature Medicine.

[37]  Ralph Weissleder,et al.  Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice. , 2002, Gastroenterology.

[38]  H Messmann,et al.  Fluorescence endoscopy for the detection of low and high grade dysplasia in ulcerative colitis using systemic or local 5-aminolaevulinic acid sensitisation , 2003, Gut.

[39]  Bernard Burnand,et al.  Impact of colonic cleansing on quality and diagnostic yield of colonoscopy: the European Panel of Appropriateness of Gastrointestinal Endoscopy European multicenter study. , 2005, Gastrointestinal endoscopy.

[40]  Hisataka Kobayashi,et al.  Toxicity of Organic Fluorophores Used in Molecular Imaging: Literature Review , 2009, Molecular imaging.

[41]  S. Batra,et al.  Effects of humanization and gene shuffling on immunogenicity and antigen binding of anti‐tag‐72 single‐chain Fvs , 2001, International journal of cancer.

[42]  R. Kiesslich,et al.  In-vivo confocal real-time mini-microscopy in animal models of human inflammatory and neoplastic diseases. , 2007, Endoscopy.

[43]  R. Kiesslich,et al.  In vivo molecular imaging with cetuximab, an anti-EGFR antibody, for prediction of response in xenograft models of human colorectal cancer , 2013, Endoscopy.

[44]  Kemin Wang,et al.  Luminescent nanoparticle probes for bioimaging. , 2004, Journal of nanoscience and nanotechnology.

[45]  R Weissleder,et al.  In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. , 2000, Cancer research.

[46]  R. Kiesslich,et al.  Novel colonoscopic imaging. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[47]  Tristan Barrett,et al.  Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes , 2009, Nature Medicine.

[48]  K. Kinzler,et al.  Cancer genes and the pathways they control , 2004, Nature Medicine.

[49]  Using live cells to generate aptamers for cancer study. , 2010, Methods in molecular biology.

[50]  M. van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.

[51]  H. Brenner,et al.  Efficacy of a nationwide screening colonoscopy program for colorectal cancer. , 2012, Gastroenterology.

[52]  J. Baselga,et al.  Targeting epidermal growth factor receptor in lung cancer , 2002, Current oncology reports.

[53]  W. Domschke,et al.  Fluorescence Endoscopy Using a Fluorescein-Labeled Monoclonal Antibody Against Carcinoembryonic Antigen in Patients with Colorectal Carcinoma and Adenoma , 2002, Endoscopy.

[54]  H Messmann,et al.  Endoscopic fluorescence detection of low and high grade dysplasia in Barrett's oesophagus using systemic or local 5-aminolaevulinic acid sensitisation , 2001, Gut.

[55]  M. Wallace,et al.  Molecular imaging in gastrointestinal disease. , 2007, Gastroenterology.

[56]  Martin Goetz,et al.  Molecular in vivo imaging of gastric cancer in a human-murine xenograft model: targeting epidermal growth factor receptor. , 2012, Gastrointestinal endoscopy.

[57]  Ralph Weissleder,et al.  Colonic adenocarcinomas: near-infrared microcatheter imaging of smart probes for early detection--study in mice. , 2007, Radiology.

[58]  D. Morgan,et al.  Biochromoendoscopy: molecular imaging with capsule endoscopy for detection of adenomas of the GI tract. , 2008, Gastrointestinal endoscopy.

[59]  D. Rex,et al.  Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. , 1997, Gastroenterology.

[60]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[61]  R. Weissleder,et al.  In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.

[62]  Paul Fockens,et al.  Probe-based confocal laser endomicroscopy. , 2009, Gastroenterology.

[63]  Shuji Ogino,et al.  Optical Imaging with a Cathepsin B Activated Probe for the Enhanced Detection of Esophageal Adenocarcinoma by Dual Channel Fluorescent Upper GI Endoscopy , 2012, Theranostics.

[64]  R. Kiesslich,et al.  In vivo molecular imaging of gastric cancer by targeting MG7 antigen with confocal laser endomicroscopy , 2013, Endoscopy.

[65]  E. Krenning,et al.  ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogs , 2009, Neuroendocrinology.

[66]  E. G. Hahn,et al.  Fluorescence induced with 5-aminolevulinic acid for the endoscopic detection and follow-up of esophageal lesions. , 2001, Gastrointestinal endoscopy.

[67]  Hisataka Kobayashi,et al.  Fluorescence endoscopic detection of murine colitis-associated colon cancer by topically applied enzymatically rapid-activatable probe , 2012, Gut.

[68]  杨朝勇.  Aptamers evolved from live cells as effective molecular probes for cancer study , 2006 .

[69]  P. Bossuyt,et al.  Polyp Miss Rate Determined by Tandem Colonoscopy: A Systematic Review , 2006, The American Journal of Gastroenterology.

[70]  Paul Fockens,et al.  Endoscopic trimodal imaging detects colonic neoplasia as well as standard video endoscopy. , 2011, Gastroenterology.

[71]  S. Yalamarthi,et al.  Missed Diagnoses in Patients with Upper Gastrointestinal Cancers , 2004, Endoscopy.

[72]  Martin Goetz,et al.  Confocal laser endomicroscopy in gastrointestinal diseases , 2011, Journal of biophotonics.

[73]  Shinji Tanaka,et al.  AIM TO UNIFY THE NARROW BAND IMAGING (NBI) MAGNIFYING CLASSIFICATION FOR COLORECTAL TUMORS: CURRENT STATUS IN JAPAN FROM A SUMMARY OF THE CONSENSUS SYMPOSIUM IN THE 79TH ANNUAL MEETING OF THE JAPAN GASTROENTEROLOGICAL ENDOSCOPY SOCIETY , 2011, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[74]  J. Schulzke,et al.  Nano- and microscaled particles for drug targeting to inflamed intestinal mucosa: a first in vivo study in human patients. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[75]  D. Naisbitt,et al.  Idiosyncratic Adverse Drug Reactions: Current Concepts , 2013, Pharmacological Reviews.

[76]  Myung-Gyu Choi,et al.  Recent advances in targeted endoscopic imaging: Early detection of gastrointestinal neoplasms. , 2012, World journal of gastrointestinal endoscopy.

[77]  Thomas D. Wang,et al.  Targeted endoscopic imaging. , 2009, Gastrointestinal endoscopy clinics of North America.

[78]  S. Brophy,et al.  Interventions for latent autoimmune diabetes (LADA) in adults. , 2011, The Cochrane database of systematic reviews.

[79]  Eben L Rosenthal,et al.  Optical imaging predicts tumor response to anti-EGFR therapy , 2010, Cancer biology & therapy.

[80]  Endoscopic Innovations,et al.  The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on real-time endoscopic assessment of the histology of diminutive colorectal polyps , 2011 .